Sputnik V vaccine from Russia is 91.6% effective 0:50
(CNN Spanish) -
The Russian Fund for Direct Investment reported this Wednesday through a statement that the Nicaraguan Ministry of Health authorized the use of the Sputnik V vaccine. According to the document, the health authorities of the Central American country approved the emergency use of the vaccine without registration of clinical trials.
With Nicaragua, there are already 6 Latin American countries that have authorized the Russian vaccine.
Previously, Paraguay, Venezuela, Mexico, Argentina and Bolivia did.
Russian Sputnik V Vaccine 91.6% Effective in Preventing Covid-19, Interim Analysis Suggests
Russia seeks allies to manufacture its Sputnik V vaccine in the world 2:21
Sputnik V, the coronavirus vaccine developed in Russia, is 91.6% effective in preventing symptomatic COVID-19 and 100% effective in preventing serious illness, according to an interim analysis of published phase 3 trial data. this Tuesday in the medical journal The Lancet.
sputnik VVaccine against coronavirus